Tweets
Highly allergic can safely get the COVID Vax. Israeli study of 8102 pts w/ allergies recv Pfizer mRNA vax - 429 were highly allergic-->98% of the highly allergic had no allergic rxns, 1% mild allergic resp & 3 anaphylactic rxns Rx w/ EPI, none hospitalized https://t.co/ATYs5R5AQC https://t.co/owNEACH1pe
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
New podcast available! Download wherever you get your podcasts.
https://t.co/4jTBhYDzRn https://t.co/DUWVD89JJ5
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
ICYMI:
FDA slaps new BOXED warning revision on ALL JAK inhibitors (Xeljanz, Olumiant, Rinvoq) after final revew of the Pfizer Oral Surveillance study. New warnings for incr risk of MI, CVA, VTE, lymphoma & death see w/ BOTH dose of tofacitinib. https://t.co/tvTv40oy59
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
500 Turkish pts from 4 pediatric rheum clinics. Oligoart. JIA (oJIA) was most common (39%), then enthesitisJIA (ERA-23%), RF neg polyarthritis (16%), RF+ poly (2.2%), Systemic JIA (16%), juvenile PsA (5.2%). Uveitis most common in oJIA (13%), then ERA (5%) https://t.co/a7O1RBM1xJ https://t.co/woSafvVsmA
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Not All Immunosuppression Alters Vaccine Immunogenicity
https://t.co/I9sShpMLBO https://t.co/oz9Qp1HM1e
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
FDA JAKi Warnings, 2nd Panel of rheumatologists weigh in on this. Drs. Cush, Dao, Tate, Sparks, Shergy. https://t.co/0WqeV6jKex via @YouTube #RheumNow @KDAO2011 @uptoTate @jeffsparks @WilliamShergy
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
FDA JAK inhibitor warnings and what it means (also: what do you think?); other news released this week; and, two questions submitted from listeners. Dr. Cush discusses this and more in this week's podcast.
https://t.co/4jTBhYDzRn https://t.co/lMpl2IOeXe
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Expert Panel: Initial Views on FDA Warnings for JAK Inhibitors
https://t.co/omeZyprT96 https://t.co/zXlGpEK6cC
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
FORWARD prospective registry showed Obesity to be associated with a substantially higher risk of incident chronic opioid use (HR adj 1.74). Approximately 1 in 4 cases of incident strong opioid use can be attributable to obesity ((HRadj 2.11) https://t.co/R0KhH4b05g https://t.co/HGHeqh4B0c
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
PhIII trial of Baricitinib vs placebo in hospitalized COVID-19 pts (91% steroids, 13% remdesivir). While no diff (28 vs 30%) in primary outcome (O2, ventilation, death). BARI had signif better Mortality @28d (8 vs 13%) & 60d (10 vs 15%) w/ no incr in VTE https://t.co/AjoRgEKW8G
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Highly allergic can safely get the COVID Vax. Israeli study of 8102 pts w/ allergies recv Pfizer mRNA vax - 429 were highly allergic-->98% of the highly allergic had no allergic rxns, 1% mild allergic resp & 3 anaphylactic rxns Rx w/ EPI, none hospitalized https://t.co/ATYs5R5AQC https://t.co/RoYU2vVLl2
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
Did you know that we have large library of downloads available for use in education? Head to RheumNow and download today.
https://t.co/CEbS8eDs1j https://t.co/VTJWYUrm8U
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 11 months ago
